Amid swirling fear and finger-pointing, Sanofi Pasteur on Wednesday released its latest clinical trials showing that its H1N1 vaccine is safe and said it can deliver the 75 million doses as promised by the end …
Read Original Story: Sanofi Pasteur says H1N1 vaccine is safe – Allentown Morning Call
CAMBRIDGE, Massachusetts (Reuters) – Production of H1N1 swine flu vaccine at two US facilities is "working optimally" with output on the rise, the chief executive of Sanofi-Aventis said on Tuesday. The French pharmaceutical giant had …
Read Original Story: U.S. H1N1 vaccine output rising quickly: Sanofi CEO – Reuters
SWIFTWATER, Pa. – Sanofi-Aventis Group, under pressure with other vaccine-makers to meet intense public demand for flu vaccine in the United States, today said it solved problems that had slowed production and was working …
Read Original Story: Sanofi says it'll deliver on flu vaccine – Philadelphia Inquirer
Who’s at fault for the slow-to-market H1N1 vaccine? USA Today asked consumers, and more than half of them blamed drug companies. Some 62 percent said they blame pharma either a great deal or moderately. The government, by contrast, got 58 percent of …
Read Original Story: US blames drugmakers for slow flu shots – FiercePharma
Chris Viehbacher, the CEO of Sanofi-Aventis, told the Health Blog a while back that he planned to shift a big chunk of research funding away from Sanofi’s internal labs and toward external partnerships with smaller, …
Read Original Story: Sanofi's Research Shift: Billion-Dollar Deal, Venture Capital Fund – Wall Street Journal (blog)
CAMBRIDGE, Mass., Nov 10 (Reuters) – Production of H1N1 swine flu vaccine at two facilities in Pennsylvania is "working optimally," with output on the rise, the chief executive of Sanofi-Aventis SA (SASY.PA) said on Tuesday. …
Read Original Story: Sanofi CEO-US H1N1 vaccine output rising quickly – Reuters
Nov 11, 2009 (CIDRAP News) – After a slow start in producing H1N1flu vaccine, Sanofi Pasteur has improved yields threefold and expects to fulfill its government order for 75 million doses by the end of the year, company officials said today. …
Read Original Story: Sanofi vows to finish making H1N1 vaccine by year's end – CIDRAP
SWIFTWATER, Pa., Nov. 11 /PRNewswire/ — Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today the final analyses of data from clinical trials of the US licensed Influenza A (H1N1) 2009 …
Read Original Story: Video: Sanofi Pasteur Announces Final Results of US Clinical Trials of … – CNNMoney.com (press release)
CAMBRIDGE, Mass. (Dow Jones)–French pharmaceutical giant Sanofi-Aventis SA (SA) is interested in setting up a venture capital fund to help develop strategic partnerships with drug-developers, Chief Executive Christopher Viehbacher said Tuesday. …
Read Original Story: Sanofi-Aventis Interested In Fund To Develop Partners – Wall Street Journal
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why Boston-area biotech companies should want to form partnerships with the French drug giant. It was an impressive show of force by the …
Read Original Story: Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston … – Xconomy
